Zudong L. Meng
39 Middle Chaoyang Road
Shiyan, 442000, China
Shiyan, 442000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Comment on 'Nail matrix melanoma in adolescents and young adults: a retrospective dermoscopic study': Do observations justify revision of diagnostic criteria?
Journal: Clinical and experimental dermatology
Published: June 08, 2026
Comment on 'Clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distribution: a multicentre cohort study': Does observed stabilization necessarily reflect disease control?
Journal: Clinical and experimental dermatology
Published: June 08, 2026
SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.
Journal: Frontiers in immunology
Published: February 13, 2026
A Global Study of Skin and Subcutaneous Diseases Among Individuals Under 20 Years of Age.
Journal: Clinical, cosmetic and investigational dermatology
Published: February 06, 2026
A randomized phase 2 trial of socrodeucitinib in moderate-to-severe plaque psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 26, 2026
HS-20137 for Chinese Moderate-to-Severe Psoriasis: A Randomized, Double-Blinded, Phase 2 Study.
Journal: Dermatology and therapy
Published: January 14, 2026
Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.
Journal: American journal of clinical dermatology
Published: January 13, 2026
Immunological Antagonism Between Psoriasis and Atopic Dermatitis: Pathways, Clinical Implications, and Therapeutic Perspectives.
Journal: Clinical, cosmetic and investigational dermatology
Published: October 17, 2025
Anti-IL-4Rα antibody SHR-1819 for moderate-to-severe atopic dermatitis: a randomized phase 2 study.
Journal: BMC medicine
Published: August 13, 2025
Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial.
Journal: Journal of the American Academy of Dermatology
Published: July 08, 2025
Superior efficacy and comparable safety of calcipotriol plus betamethasone dipropionate foam vs. ointment in Chinese patients with plaque psoriasis: A randomized phase 3 trial.
Journal: Chinese medical journal
Published: March 21, 2025
Last Updated: 09/26/2026